Tokyo Tape
Sign in
← CareNet

Quarterly report · Q1

2150.TEDINET S100TFC8
Period2024-01-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-01-01 → 2024-03-31Cons.Net sales
Revenue¥10.2bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥2.5bn2023-01-01 → 2023-03-31Cons.Net sales
Operating income¥545m2024-01-01 → 2024-03-31Cons.Operating income
Operating income¥715m2023-01-01 → 2023-03-31Cons.Operating income
Ordinary income¥564m2024-01-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥2.5bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥716m2023-01-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥516m2024-01-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥716m2023-01-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥311m2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥458m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥330m2024-01-01 → 2024-03-31Cons.Profit loss
Net income¥464m2023-01-01 → 2023-03-31Cons.Profit loss
Total assets¥13.5bnat 2024-03-31Cons.Assets
Total assets¥14.2bnat 2023-12-31Cons.Assets
Total assets¥12.4bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥2.3bnat 2024-03-31Cons.Liabilities
Total liabilities¥2.7bnat 2023-12-31Cons.Liabilities
Net assets / equity¥11.2bnat 2024-03-31Cons.Net assets
Net assets / equity¥11.5bnat 2023-12-31Cons.Net assets
Net assets / equity¥10.2bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥8.0bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥8.9bnat 2023-12-31Cons.Cash and deposits
EPS (basic)¥6.982024-01-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥33.92023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.272023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio81.7%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 25
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥2m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥2m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31−¥423m
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥2.4bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥2.4bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥1m
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentsegment profit2024-01-01 → 2024-03-31¥946m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥266m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥265m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥500,000
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentsegment profit2024-01-01 → 2024-03-31¥23m
—segment totalrevenue2024-01-01 → 2024-03-31¥2.7bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥2.7bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥2m
—segment totalsegment profit2024-01-01 → 2024-03-31¥968m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥336m
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥2.3bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥2.3bn
jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥985m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥227m
jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥66m
—segment totalrevenue2023-01-01 → 2023-03-31¥2.5bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥2.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 334
ItemContextValueUnit
Net defined benefit liabilityCurrentQuarterInstant16529000JPY
Asset retirement obligations nclPrior1YearInstant51797000JPY
Asset retirement obligations nclCurrentQuarterInstant51820000JPY
Reserve for officer stock benefitsPrior1YearInstant59598000JPY
Reserve for officer stock benefitsCurrentQuarterInstant65016000JPY
Reserve for employee stock benefitsPrior1YearInstant8265000JPY
Reserve for employee stock benefitsCurrentQuarterInstant－JPY
Other nclPrior1YearInstant13100000JPY
Other nclCurrentQuarterInstant17005000JPY
Noncurrent liabilitiesPrior1YearInstant218879000JPY
Noncurrent liabilitiesCurrentQuarterInstant216609000JPY
LiabilitiesPrior1YearInstant2667265000JPY
LiabilitiesCurrentQuarterInstant2303712000JPY
Capital stockPrior1YearInstant2405636000JPY
Capital stockCurrentQuarterInstant2405636000JPY
Capital surplusPrior1YearInstant3073797000JPY
Capital surplusCurrentQuarterInstant3073797000JPY
Retained earningsPrior1YearInstant6486661000JPY
Retained earningsCurrentQuarterInstant6258272000JPY
Treasury stockPrior1YearInstant-700753000JPY
Treasury stockCurrentQuarterInstant-700753000JPY
Shareholders equityPrior1YearInstant11265340000JPY
Shareholders equityCurrentQuarterInstant11036952000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-28292000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-3775000JPY
Valuation and translation adjustmentsPrior1YearInstant-28292000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-3775000JPY
Subscription rights to sharesPrior1YearInstant0JPY
Subscription rights to sharesCurrentQuarterInstant0JPY
Non controlling interestsPrior1YearInstant264467000JPY
Non controlling interestsCurrentQuarterInstant168543000JPY
Net assetsPrior1YearInstant11501516000JPY
Net assetsCurrentQuarterInstant11201721000JPY
Liabilities and net assetsPrior1YearInstant14168782000JPY
Liabilities and net assetsCurrentQuarterInstant13505434000JPY
Net salesPrior1YTDDuration2526715000JPY
Net salesCurrentYTDDuration2667149000JPY
Cost of salesPrior1YTDDuration934253000JPY
Cost of salesCurrentYTDDuration1087003000JPY
Gross profitPrior1YTDDuration1592461000JPY
Gross profitCurrentYTDDuration1580145000JPY
Selling general and administrative expensesPrior1YTDDuration877401000JPY
Selling general and administrative expensesCurrentYTDDuration1034894000JPY
Operating incomePrior1YTDDuration715060000JPY
Operating incomeCurrentYTDDuration545251000JPY
Interest income noiPrior1YTDDuration588000JPY
Interest income noiCurrentYTDDuration1213000JPY
Equity in earnings of affiliates noiPrior1YTDDuration－JPY
Equity in earnings of affiliates noiCurrentYTDDuration11055000JPY
Foreign exchange gains noiPrior1YTDDuration194000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass